Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

Share on Pinterest GLP-1 and SGLT-2 drugs may be the best treatments for people with type 2 diabetes and COPD. Image credit: Visual Vic/Getty Images. Researchers estimate the number of people ...

Although these products might confer significant advantages over the currently available treatments, there is still a huge unmet need for drugs that prevent the progression of COPD. Companies are ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

A new study suggests COPD patients experience improved lung ... as both can be fearful of losing control of the disease in a change of medication. The CRYSTAL trial is the first large-scale ...

Please provide your email address to receive an email when new articles are posted on . Significantly more patients from the injurious fall group had all but one of the studied prescription ...

There are certain risk factors for COPD, including obesity and having type 2 diabetes. A new study has found that people who have type 2 diabetes who are treated with GLP-1 and SGLT-2 medications ...